Neoplasms Metastasis Completed Phase 2 Trials for Panitumumab (DB01269)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00034346ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)Treatment
NCT00101920ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)Treatment